Department of Rehabilitation, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, China.
Hubei Provincial Collaborative Innovation Center of Preventive Treatment by Acupuncture and Moxibustion, Wuhan, China.
Obes Facts. 2020;13(1):40-57. doi: 10.1159/000503752. Epub 2020 Jan 14.
To investigate the anorexigenic and anti-obesity effectiveness of electroacupuncture (EA) on high-fat-diet-induced (HFDI) obese rats with insulin resistance (IR) and to reveal the possible mechanisms of EA affecting SIRT1 (silent mating type information regulation 2 homolog 1) in the central nervous system (CNS).
We divided 60 rats into 6 groups. All interventions, including EA and intracerebroventricular administration, were performed after 8 weeks of model establishment. We tested obesity phenotypes like body weight (BW) gain; food intake; and IR levels including glucose infusion rate, intraperitoneal insulin tolerance test (IPITT), and intraperitoneal glucose tolerance test (IPGTT) during treatment. We detected protein expression and microscopic locations in hypothalamic SIRT1, the transcription factor FOXO1 (forkhead box protein O1), acetylated FOXO1 (Ac-FOXO1), pro-opiomelanocortin (POMC), and neuropeptide Y (NPY) via Western blotting and immunofluorescence, and monitored gene expression by real-time polymerase chain reaction.
Like the SIRT1 agonist, EA suppressed BW gain and IR levels in obese rats, but this was only partially blocked by the SIRT1 antagonist. EA could upregulate protein expression of hypothalamic SIRT1 and downregulate the acetylation level of FOXO1 in the hypothalamic arcuate nucleus (ARC), which decreased gene expression of NPY and increased that of POMC. The agonist targeted the hypothalamic SIRT1 gene, unlike EA, which targeted posttranscriptional regulation.
EA could improve obesity in HFDI rats with IR via its anorectic effect. This effect targeted posttranscriptional regulation of the SIRT1 gene, which induced upregulation of ARC FOXO1 deacetylation and mediated the gene expression of POMC and NPY.
研究电针对高脂肪饮食诱导(HFDI)肥胖伴胰岛素抵抗(IR)大鼠的食欲抑制和抗肥胖作用,并揭示电针对中枢神经系统(CNS)中 SIRT1(沉默交配型信息调节 2 同源物 1)的影响的可能机制。
将 60 只大鼠分为 6 组。所有干预措施,包括电针和侧脑室给药,均在模型建立 8 周后进行。我们在治疗期间测试了肥胖表型,如体重(BW)增加、食物摄入和 IR 水平,包括葡萄糖输注率、腹腔内胰岛素耐量试验(IPITT)和腹腔内葡萄糖耐量试验(IPGTT)。我们通过 Western blot 和免疫荧光检测下丘脑 SIRT1、转录因子 FOXO1(叉头框蛋白 O1)、乙酰化 FOXO1(Ac-FOXO1)、前阿黑皮素原(POMC)和神经肽 Y(NPY)的蛋白表达和微观位置,并通过实时聚合酶链反应监测基因表达。
与 SIRT1 激动剂一样,电针抑制肥胖大鼠的 BW 增加和 IR 水平,但这仅部分被 SIRT1 拮抗剂阻断。电针可以上调下丘脑 SIRT1 的蛋白表达,并下调下丘脑弓状核(ARC)中 FOXO1 的乙酰化水平,从而降低 NPY 的基因表达并增加 POMC 的基因表达。与电针不同,激动剂针对下丘脑 SIRT1 基因,而不是针对转录后调节。
电针通过其食欲抑制作用改善 HFDI 肥胖伴 IR 大鼠的肥胖。这种作用针对 SIRT1 基因的转录后调节,诱导 ARC FOXO1 去乙酰化的上调,并介导 POMC 和 NPY 的基因表达。